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IN previous communications (Powell, 1944, 1946a, 1946b, 1947) it has been
suggested that many of the typical properties of tumour cells can be explained
by the occurrence of a derangement of the submicroscopic protein framework
of their protoplasm. It was also suggested that the growth of malignant cells
might be inhibited by chemical compounds able to link together the ultra-
structural protein fibrils of tumour cells, and thus simulate the arrangement of
comparable fibrils in normal cells.
Disulphide bridges constitute one of the more important classes of inter-
connections between the fibrils of native proteins. The rupture of disulphide
bridges may result in paired thiol groups which can be interlinked by quinones.
Quinones can also cross-link protein fibrils by combining with amino and imino
groups (Sexton, 1949). In an earlier communication (Powell, 1944) it was
reported that certain quinones, and other compounds with a comparable effect
on proteins, inhibited the growth of Twort carcinomas in mice.
Quinones have been reported to act as mitotic poisons on fibroblasts grown in
tissue culture (Meier and Allgower, 1945; Meier and Schar, 1947) and on the
cells ofdeveloping eggs ofthe fresh-water annelid Tubifex (Lehmann, 1942, 1945;
Huber, 1945, 1947). Mitchell and Simon-Reuss (1947) have described the inhi-
bitory effect of tetrasodium 2-methyl-1 : 4-naphthohydroquinone (" Synkavit ")
on normal and malignant cells grown in vitro. Mitchell (1948) has also reported
increased radiosensitivity in tumours of patients concurrently treated with
"Synkavit." However, Gellhorn and Gagliano (1950) subsequently claimed
that" Synkavit " had no appreciableinhibitoryeffect onthegrowth oftransplant-
able tumours in mice and rabbits. The bacteriostatic effects of quinones are
well known (Hoffmann-Ostenhof, 1947).
In the present series of experiments 9: 10-phenanthraquinone was used as
being the simplest readily available quinone likely to show a tumour-inhibiting
action without being too toxic for continued administration to experimental
animals.
MATERIALS AND METHODS.
Preparation of 9: 10-phenanthraquinone.
The phenanthraquinone used in the experiments described was prepared by
oxidizing phenanthrane in glacial acetic acid solution with chromium trioxide.
The reaction product was allowed to cool, diluted with water and the solids
collected by filtration. The crude quinone was well washed with water andEFFECT OF PHENANTHRAQUINONE ON MOUSE TUMOURS
extracted with sodium metabisulphite solution. The quinone was recovered
from the fitered bisulphite solution by precipitation with sodium carbonate or
sulphuric acid. Further purification was carried out by repeated formation of
the additive bisulphite compound and subsequent precipitation as above. Chloro-
form or benzene solutions ofthe purified quinone were then thoroughly extracted
with cold dilute sodium carbonate solution, washed with water and dried over
anhydrous sodium sulphate. The filtered dry quinone solution was passed
through a column of adsorbent alumina and the quinone recovered by distilling
offthe solvent and washing with ether. It was then recrystallized from acetone.
Prepared by this method, phenanthraquinone contains a variable amount of
impurity with a hot burning taste. However, preparations of phenanthra-
quinone ofsufficient purity for preliminary experimental trials on animal tumours
have been made by the method described above.
Administration ofphenanthraquinone.
Preliminary experiments had shown the necessity of continuous adminis-
tration of quinone to obtain optimum inhibition of tumour growth. Finely
ground quinone was therefore incorporated in the food given to treated mice.
This food was made up in the proportions: powdered rat cake 80 g., plain flour
20 g., quinone as desired, tap water 50 ml. The dry ingredients, including the
quinone, were thoroughly mixed, the water then added and the mixture worked
into a stiff dough, which was rolled and cut into small cubes. These were gently
dried overnight at a moderate heat. Freshly prepared food was given in excess
to treated mice each day.
Control experiments with prepared food lacking the quinone showed that it
maintained the health and growth of mice, and that their tumours grew at the
same rates as those of mice fed on the ordinary laboratory diet ofwhole rat cake
cubes.
Experimental animals.
In all the experiments inbred strains of mice were used. With the exception
of Carcinoma 63, which was grown in Strong A strain mice, the tumour strains
were homologous with the hosts. The following transplantable tumours were
used: Carcinoma 63, a fibrosarcoma (Ac) ofStrong A mice, a spindle cell tumour
and a squamous cell carcinoma ofCBA mice, a rapidly growing undifferentiated
sarcoma (Rb) and a mammary adenocarcinoma ofRIII mice.
The tumours were grafted subcutaneously in the right flanks of the mice, in
each experiment the implants being portions taken from one tumour. In each
experiment mice with actively growing tumours were divided into groups, control
and experimental. The sizes of the tumours were then recorded, and the mice
to be treated placed immediately on the diet containing quinone. The tumours
ofthe mice in each group were measured at intervals, and after the last measure-
ments the tumours from both the treated and control mice were removed for
histological study.
EXPERIMENTAL RESULTS.
The inhibitory effect of food containing 1 to 2 per cent phenanthraquinone
upon the growth ofCarcinoma 63 is illustrated in the first three charts (Fig. 1, 2,
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3). In the first experiment (Fig. 1) the grafts grew more quickly than is usual
for this strain of tumour. The sizes of the tumours at the beginning of this
experiment were also appreciably larger than in the two other experiments.
In the first experiment (Fig. 1) the majority of the tumours of the mice in
both treated groups grew during the early days of treatment, but later showed
little growth. Tumour No. 13 did, however, show considerable growth after an
initial inhibition.
C o n t r o I Treated
7 13 19 7 13 19
~0 ~0 0
20*0890· 0 0
6 4>13. *.@ X ·, 02
KLIIJ
cm.
FIG. 1.-Effect of 1 per cent phenanthraquinone upon the growth of Carcinoma 63 in A strain
mice. In allthetext-figures thehorizontallyplaced numbers indicate days after inoculation,
and the concentration of phenanthraquinone in the food is given as a percentage of the
combined weights of flour and rat cake powder.
The quinone used in this experiment possibly contained a trace of the hot
tasting impurity, buttreated mice showed no harmful effects from it. Thegrowth-
inhibitory effect of the drug is evident from a study of the chart. It became
more marked with the duration of treatment. In this experiment the control
mice were fed upon food prepared from rat cake, flour and water. Ordinary
rat cake was given to control animals in all the following experiments.
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The charts shown in Fig. 2 and 3 demonstrate the similarity of the results
obtained in different experiments with a particular strain of tumour when
the rate of tumour growth is approximately the same, and the concentration
of the drug is constant. They should be contrasted with that iri Fig. 1, in
which the growth of the control tumours is appreciably faster. Here, with a
higher concentration of the drug, smaller initial sizes and slower intrinsic growth
rates of the tumours, the inhibitory effects of the treatment are greater than in
l
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FIG. 4.-Effect of 2 per cent phenanthraquinone upon the growth of a fibrosarcoma of
A strain mice.
the first experiment (Fig. 1). At the end of the second experiment (Fig. 2) one
tumour, No. 8, had grown very slightly, three others were stationary, and the
remaining three were not visible externally. The results ofthe other experiment
with food containing 2 per cent quinone (Fig. 3) are of the same order.
The remaining charts (Fig. 4, 5, 6) demdnstrate the effects of phenanthra-
quinone upon the growth oftumours homologous with their hosts. At a concen-
tration of 2 per cent in the food, the quinone significantly inhibited the growth
of a rapidly growing fibrosarcoma ofA strain mice (Fig. 4), a spindle cell tumour
of CBA strain mice (Fig. 5), and a very rapidly growing sarcoma of RIII strain
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mice (Fig. 6). Complete regressions were observed in two ofthese latter experi-
ments.
Considering the experimental results as a whole it appears that inhibition
of tumour growth is greatest when small tumours are treated and the intrinsic
growth rate is slow. After transplanted tumours have attained a certain size,
varying with the strain, the growth-inhibiting effect of phenanlthraquinone is
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FIG. 5.-Effect of 2 per cent phenanthraquinone upon the growth of a spindle cell tumour of
CBA strain mice.
considerably less. The inhibition of several spontaneous mammary tumours
of A and RIII strains of mice by the quinone was comparable with that ofthe
transplanted tumours. Also, the growth of a transplantable mammary adeno.
carcinoma ofRIII miceand atransplantable squamous cellcarcinomaofCBA mice
was strongly inhibited. Thus the growth of a variety of different tumours can
be inhibited by phenanthraquinone under the conditions described.
Samples of phenanthraquinone containing sufficient impurity to make it
unpalatable cause loss of weight of the treated animals. Gastro-enteritis some-
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times results in such mice, but affected mice may recover completely from the
toxic effects. Inhibition of tumour growth precedes signs oftoxicity in the host
mice. Treated mice in which tumours are no longer palpable have been kept
6 to 8 weeks with no resumption of tumour growth.
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FIG. 6.-Effect of 2 per cent phenanthraquinone upon the growth of an undifferentiated
sarcoma of RIII strain mice.
DISCUSSION.
The results of the experiments described demonstrate that the growth of
animal tumours can be inhibited by the administration of phenanthraquinone.
The quinone prepared by the methods used in the present work from naturally
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occurring phenanthrene has the very considerable disadvantage of being fre-
quently contaminated by hot tasting impurity. The latter causes prepared food
to be unpalatable, and can give rise, if present in sufficient amount, to gastro-
enteritis. But, by comparing the effects ofsamples ofquinone ofvarying degrees
ofpalatability, it has been established that the purest samples are the least toxic
to mice and inhibit tumourgrowth to thegreatest extent. This greaterinhibition
oftumour growth may be due in part to a greater intake of food, andtherefore
of quinone. Detailed investigation of the effects of phenanthraquinone upon
tumours and of its possible value in tumour chemotherapy is dependent upon
the preparation of the drug in a pure state. Its further purification and alter-
native methods ofsynthesis are under investigation.
The additive compound ofphenanthraquinone with sodium metabisulphite is
very readily hydrolyzed in vivo to yield the free quinone. Serial intraperitoneal
injections in mice of aqueous solutions of the quinone-bisulphite compound in
sub-lethal doses at frequent intervals indicate that the liberated quinone is very
rapidly metabolized in thebody. In view oftherapid destruction ofphenanthra-
quinone in vivo and of the rapid growth rates of many tumours, it is essential
that continuous administration of the drug be maintained in order to expose the
tumour cells to an effective concentration ofthe drug for sufficiently long periods.
Failure to achieve this could permit a proportion ofthe tumour cells to grow and
divide. In the early stages of an experiment cessation of treatment with the
quinone may result, in some instances, in stationary tumours recommencing
growth. On the other hand, similar tumours continually subjected to the action
of the quinone fail to grow and often regress completely. In these preliminary
experiments the simplest method of ensuring an adequate and continual supply
of the quinone, namely, by adding it to the food, was adopted. However, this
method is not entirely satisfactory. Adequately controlled experiments in which
individual mice receive known amounts ofquinone at definite times are necessary
for detailed studies of the action ofthe drug.
Very little of the quinone in a concentration of 1 to 2 per cent in the food
ingested by a mouse can be available for action on substrates in tumour cells,
since there is a very great disparity between this amount and the lethal dose
given as thebisulphite derivative by injection. Much ofthe fed quinone may not
be absorbed from the food, and the greater part ofthat reaching the body fluids
may be metabolized.
Sodium salts ofthe phosphoric and sulphuric acid esters of 9: 10-phenanthra-
hydroquinone have been synthesized and tested for possible inhibitory effects
on tumour growth, but they have been found to be unsuitable for the treatment
oftumour-bearing mice. The former very readily hydrolyzes to give the hydro-
quinone, which readily oxidizes to the quinone, and the latter is extremely
resistant to hydrolysis.
Preliminary experiments upon the administration ofthiol compounds concur-
rently with phenanthraquinone to tumour-bearing mice appear to indicate that
the latter reacts with thiol groups in vivo. Its inhibitory action on tumour
growth may be due, at least in part, to this effect. The antibacterial effect of
some quinones has been attributed by Cavallito (1946) to their interaction with
thiol groups. It is known that quinones can react as oc, (-unsaturated ketones,
resulting in the additioni of compounds through thiol and amino groups (Sexton,
1949). The ability of the quinonoid structure to undergo reversible reduction
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may enable phenanthraquinone to function as an oxidation-reduction catalyst
and so disturb the natural oxidation-reduction balance of tumour cells, possibly
to a greater extent than that of most normal cells. In view of its considerable
chemical reactivity, as well as of its affinity for proteins, phenanthraquinone
would be expected to have multiple effects on cells. Despite the possibility that
phenanthraquinone has in vivo the mode of action postulated earlier, that is, of
forming cross-linkages between ultra-structural protein fibrils, it is emphasized
that its actual mode ofaction remains a completely open question. The available
evidence favours the view that over a certain range of concentration tumour cells
are more sensitive than normal cells to the effects ofphenanthraquinone.
It has been reported by Mitchell (1948) that the combined antimitotic effect
of "Synkavit" and x-rays is greater than the additive effects of both agents
used singly. A similar relation holds for the effects of phenanthraquinone and
x-rays upon the growth ofmouse tumours.
SUMMARY.
1. When fed to tumour-bearing mice 9: 10-phenanthraquinone has an
inhibitory effect on tumour growth.
2. Inhibition ofthe growth ofthe following tumours has been demonstrated:
Carcinoma 63 in A strain mice, a fibrosarcoma of A strain mice, a spindle cell
tumourand asquamous cell carcinoma ofCBA mice, a rapidly growingundifferen-
tiated sarcoma and a mammary adenocarcinoma of RIII mice, and spontaneous
mammary tumours ofA and RIII mice.
3. It is suggested that phenanthraquinone reacts with sulphydryl or other
accessible radicles of proteins, and may induce changes in the fibrous ultra-
structural protein framework ofthe protoplasm of tumour cells.
4. Some possible modes of action of phenanthraquinone upon malignant
cells are discussed.
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